Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions
Listen to experienced industry panellists engage in a thought-provoking discussion relating to new technologies within drug discovery.
Kam Dhaliwal | SVP Alliance Management | bit.bio (chair)
Steve Rees | Vice President Discovery Biology | AstraZeneca
Benedict Cross | Chief Technology Officer | PhoreMost Ltd
Tilmann Buerckstuemmer | Chief Scientific Officer | Aelian Biotechnology GmbH
Marijn Vlaming | Head of Biology | Beerse & Leiden | Charles River Laboratories
bit.bio panel discussion at ELRIG Drug Discovery Digital